360° Coverage : Mega Millions For Intercept Pharmaceuticals Shareholders. What...

2 Updates

Mega Millions For Intercept Pharmaceuticals Shareholders. What's Next?

Jan 11 2014, 11:31am CST | by

When thinking of mega millions winners, we usually think of people who purchased lucky lottery tickets. This week, we should count as mega millions winners another category: investors who purchased...

Filed under: news

 
 
 

35 weeks ago

Mega Millions For Intercept Pharmaceuticals Shareholders. What's Next?

Jan 11 2014, 11:31am CST | by

When thinking of mega millions winners, we usually think of people who purchased lucky lottery tickets. This week, we should count as mega millions winners another category: investors who purchased shares in a small biotechnology company, Intercept Pharmaceuticals, Inc., before the closing of Wall Street on Wednesday — at around $72 or better at the 52wk low of $30.38.

The stock climbed to $275.87 on Thursday, and to $497 during the trading time on Friday, valuing the company close to $9 billion.

Now, think of the company insiders who held roughly 43 percent of the 13.4m of outstanding shares; the institutions, who held another 26 percent; and the individuals who held a few thousand before Thursday.

You can do the math.

The catalyst for these astronomical gains? The company’s liver-disease drug, which performed unexpectedly well in a clinical trial.

“The drug, called obeticholic acid, or OCA, mimics a naturally occurring human bile acid that Intercept believes has liver-protective properties,” writes Peter Loftus of Wall Street Journal.

But does the potential market for the drug justify the company’s current valuation?

ICPT key statistics

Market cap (intraday) 8.73B
Shares Outstanding 19.34M
%Held by insiders 42.7%
%Held by institutions 26.10%
Revenue 1.62M
Operating Cash Flow -21.87M

Source:Yahoo.Finance.com1/10/14

Obviously, investors buying shares on Friday believe so. I would be skeptical, however, for a number of reasons:

First, we are talking about a drug that performed well in a statistical trial, not a drug that has already received FDA approval. “Many experimental drugs fail to make it to the market, so Intercept’s OCA could stumble,” continues Peter Loftus. “But the clinical trial outcome raised investors’ expectations that the company could have a big-selling product on hands.”

Second, even if OCA receives an expedient FDA approval, marketing success is no guarantee. Investors have to look no further than the fate of Dendreon’s drug PROVENGE that received FDA approval a few years ago.

Third, even if OCA passes both the FDA and the market test, at the current market valuation, the company is valued at 10 percent of the value of Amgen Inc., which has been around for more than three decades and has several blockbuster stocks in the market.

Investors who have been around Wall Street long enough remember EntreMed Inc, another biotechnology company that displayed a similar performance in a short period. We all know what happened in that case.

Source: Forbes Business

 
Update
2

2 weeks ago

Khazanah throws MAS RM6b lifeline

Aug 29 2014 5:01pm CDT | Source: Business Times Singapore

August 30, 2014 1:15 AMKHAZANAH Nasional will inject RM6 billion (SS$2.4 billion) over three years to resuscitate loss-making Malaysia Airlines (MAS) under a recovery plan that includes even an Act of Parliament. Other key moves are migrating its operations, assets and liabilities to a new company (NewCo) and slashing the workfor ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 
Update
1

2 weeks ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of the double tragedie ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Why marijuana users end up feeling worse
New York, Sep 15 (IANS) Adolescents and young adults who smoke marijuana frequently may attempt to manage negative moods by using the drug but end up feeling worse, says a new study.
 
 
Schizophrenia a group of eight distinct disorders: Study
Washington, Sep 15 (IANS) The debilitating psychiatric illness schizophrenia is not a single disease but a group of eight genetically distinct disorders - each with its own set of symptoms, new research indicates.
 
 
'Old climate change formula no longer exists'
Washington, Sep 15 (IANS) The traditional formula on climate change that says that regions that have a moist climate will experience additional rainfall is no longer valid, scientists say.
 
 
OPEC daily basket price closes higher
Vienna, Sep 15 (IANS/WAM) The basket of 12 crude oils of the Organisation of Petroleum Exporting Countries (OPEC) closed at $95.68 a barrel Friday, compared to $95.35 a barrel last Thursday, the OPEC Secretariat said.
 
 
 

Latest from the Network

New Zealand PM declassifies spy documents
Wellington, Sep 15 (IANS) New Zealand Prime Minister John Key Monday released previously classified documents regarding the country's security agencies as his government became the latest target of claims by US spy...
Read more on Politics Balla
 
Libyan PM rejects talks with armed Islamist group
Tripoli, Sep 15 (IANS) Libyan Prime Minister Abdullah al-Thinni has ruled out any negotiations with the Libya Dawn Islamist armed alliance, saying the government will launch new assaults to wipe it out. Sky News...
Read more on Politics Balla
 
Toll in Philippines ferry capsize rises to six
Manila, Sep 15 (IANS) The toll from the sinking of a ship off Panaoan island in the central Philippine province of Southern Leyte has climbed to six, the Philippine Navy said Monday. Marineth Domingo, spokesman of the...
Read more on Politics Balla
 
Why marijuana users end up feeling worse
New York, Sep 15 (IANS) Adolescents and young adults who smoke marijuana frequently may attempt to manage negative moods by using the drug but end up feeling worse, says a new study. "Marijuana use is a vicious circle...
Read more on Celebrity Balla
 
App to track what makes you truly happy
Washington, Sep 15 (IANS) Do you think the smartphone is a source of undue stress? Try this app created by three students at the University of California-Berkeley that claims to make them a source of goodness. The "...
Read more on Celebrity Balla
 
Schizophrenia a group of eight distinct disorders: Study
Washington, Sep 15 (IANS) The debilitating psychiatric illness schizophrenia is not a single disease but a group of eight genetically distinct disorders - each with its own set of symptoms, new research indicates. In...
Read more on Apple Balla
 
Hillary Clinton visits Iowa, a key election state
Washington, Sep 15 (IANS/EFE) Former US secretary of state Hillary Clinton has taken part in a fundraising event in Iowa, a key state in the upcoming presidential campaign, triggering fresh speculation about her...
Read more on Politics Balla
 
Egypt court releases prominent activist on bail
Cairo, Sep 15 (IANS) An Egyptian court Monday ordered the release on bail of leading activist Alaa Abdel Fattah, who is held on charges of protesting without police permit, and referred the case to another court, media...
Read more on Politics Balla
 
'Old climate change formula no longer exists'
Washington, Sep 15 (IANS) The traditional formula on climate change that says that regions that have a moist climate will experience additional rainfall is no longer valid, scientists say. The old formula that dry...
Read more on Apple Balla
 
One Direction's new single due late September
London, Sep 15 (IANS) One Direction's next single titled "Steal my girl" from their upcoming album "FOUR" will release Sep 29. The band's Liam Payne shared the news on Twitter, reports billboard.com. A photo of the...
Read more on Celebrity Balla